Liposomal Co-Encapsulation of Two Novel Europium Complexes and Doxorubicin: Fluorescence Study

Overview

Journal J Fluoresc

Specialties Biophysics
Chemistry

Date 2017 Mar 12

PMID 28283899

Authors

Valeriya M Trusova

Todor Deligeorgiev

Galyna Gorbenko

Affiliations

Soon will be listed here.

Abstract

The present study was undertaken to design the novel liposomal drug formulation containing doxorubicin and europium coordination complexes. It was shown that co-encapsulation of the drugs facilitates the partitioning and permeation of lanthanides into the lipid bilayer. The obtained results suggest that new drug platform may have potential application in the design of novel antitumor agents.

References

Maurer N, Fenske D, Cullis P . Developments in liposomal drug delivery systems. Expert Opin Biol Ther. 2001; 1(6):923-47. DOI: 10.1517/14712598.1.6.923. View

de Wolf F, Nicolay K, de Kruijff B . Effect of doxorubicin on the order of the acyl chains of anionic and zwitterionic phospholipids in liquid-crystalline mixed model membranes: absence of drug-induced segregation of lipids into extended domains. Biochemistry. 1992; 31(38):9252-62. DOI: 10.1021/bi00153a019. View

Mathai J, Tristram-Nagle S, Nagle J, Zeidel M . Structural determinants of water permeability through the lipid membrane. J Gen Physiol. 2008; 131(1):69-76. PMC: 2174160. DOI: 10.1085/jgp.200709848. View

Ong J, Sun F, Chan E . Development of stealth liposome coencapsulating doxorubicin and fluoxetine. J Liposome Res. 2011; 21(4):261-71. DOI: 10.3109/08982104.2010.545070. View

Shmeeda H, Amitay Y, Gorin J, Tzemach D, Mak L, Stern S . Coencapsulation of alendronate and doxorubicin in pegylated liposomes: a novel formulation for chemoimmunotherapy of cancer. J Drug Target. 2016; 24(9):878-889. DOI: 10.1080/1061186X.2016.1191081. View

Harrington K, Rowlinson-Busza G, Syrigos K, Vile R, Uster P, Peters A . Pegylated liposome-encapsulated doxorubicin and cisplatin enhance the effect of radiotherapy in a tumor xenograft model. Clin Cancer Res. 2001; 6(12):4939-49. View

Speelmans G, Staffhorst RWHM , de Kruijff B . The anionic phospholipid-mediated membrane interaction of the anti-cancer drug doxorubicin is enhanced by phosphatidylethanolamine compared to other zwitterionic phospholipids. Biochemistry. 1997; 36(28):8657-62. DOI: 10.1021/bi963151g. View

Prylutskyy Y, Bychko A, Sokolova V, Prylutska S, Evstigneev M, Rybalchenko V . Interaction of C60 fullerene complexed to doxorubicin with model bilipid membranes and its uptake by HeLa cells. Mater Sci Eng C Mater Biol Appl. 2015; 59:398-403. DOI: 10.1016/j.msec.2015.10.049. View

Mickova A, Buzgo M, Benada O, Rampichova M, Fisar Z, Filova E . Core/shell nanofibers with embedded liposomes as a drug delivery system. Biomacromolecules. 2012; 13(4):952-62. DOI: 10.1021/bm2018118. View

10.

Allen T, Cullis P . Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev. 2012; 65(1):36-48. DOI: 10.1016/j.addr.2012.09.037. View

11.

Yacoub T, Reddy A, Szleifer I . Structural effects and translocation of doxorubicin in a DPPC/Chol bilayer: the role of cholesterol. Biophys J. 2011; 101(2):378-85. PMC: 3136772. DOI: 10.1016/j.bpj.2011.06.015. View

12.

Lakowicz J, Hogen D, Omann G . Diffusion and partitioning of a pesticide, lindane, into phosphatidylcholine bilayers. A new fluorescence quenching method to study chlorinated hydrocarbon-membrane interactions. Biochim Biophys Acta. 1977; 471(3):401-11. PMC: 6868474. DOI: 10.1016/0005-2736(77)90045-1. View

13.

Shaikh I, Tan K, Chaudhury A, Liu Y, Tan B, Tan B . Liposome co-encapsulation of synergistic combination of irinotecan and doxorubicin for the treatment of intraperitoneally grown ovarian tumor xenograft. J Control Release. 2014; 172(3):852-61. View

14.

Trusova V, Yudintsev A, Limanskaya L, Gorbenko G, Deligeorgiev T . Europium coordination complexes as potential anticancer drugs: their partitioning and permeation into lipid bilayers as revealed by pyrene fluorescence quenching. J Fluoresc. 2012; 23(1):193-202. DOI: 10.1007/s10895-012-1134-1. View

15.

Walls Z, Gong H, Wilson R . Liposomal Coencapsulation of Doxorubicin with Listeriolysin O Increases Potency via Subcellular Targeting. Mol Pharm. 2016; 13(3):1185-90. DOI: 10.1021/acs.molpharmaceut.5b00674. View

16.

Momekov G, Deligeorgiev T, Vasilev A, Peneva K, Konstantinov S, Karaivanova M . Evaluation of the cytotoxic and pro-apoptotic activities of Eu(III) complexes with appended DNA intercalators in a panel of human malignant cell lines. Med Chem. 2006; 2(5):439-45. DOI: 10.2174/157340606778250234. View

17.

de Wolf F, Staffhorst R, Smits H, Onwezen M, de Kruijff B . Role of anionic phospholipids in the interaction of doxorubicin and plasma membrane vesicles: drug binding and structural consequences in bacterial systems. Biochemistry. 1993; 32(26):6688-95. DOI: 10.1021/bi00077a023. View

18.

Tardi P, Gallagher R, Johnstone S, Harasym N, Webb M, Bally M . Coencapsulation of irinotecan and floxuridine into low cholesterol-containing liposomes that coordinate drug release in vivo. Biochim Biophys Acta. 2007; 1768(3):678-87. DOI: 10.1016/j.bbamem.2006.11.014. View